HCPCS Level II code A9150 denotes non-prescription drugs — over-the-counter pharmaceutical products supplied without a clinician’s prescription. Nationally, this code matters for payers and billing operations because it defines reimbursement and claim handling pathways for non-prescription items that may be billed in clinical or outpatient retail settings.

Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical framing, the typical site of service, and the payer landscape. The publication outlines administrative benchmarks and common billing considerations associated with non-prescription drug billing, summarizes relevant policy and coding guidance where applicable, and provides context on claim processing practices and audit exposure for this service line.

This summary is intended for billing managers, revenue-cycle staff, and health policy analysts seeking a national perspective on how non-prescription drugs are represented in claims through A9150 and what operational topics to monitor when these items are billed.